Stevens Capital Management LP purchased a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 32,937 shares of the company’s stock, valued at approximately $1,573,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. State Street Corp lifted its holdings in shares of Acadia Healthcare by 95.2% in the 2nd quarter. State Street Corp now owns 1,998,030 shares of the company’s stock valued at $98,667,000 after buying an additional 974,524 shares during the period. BNP Paribas Arbitrage SA lifted its holdings in shares of Acadia Healthcare by 2,358.9% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 28,843 shares of the company’s stock valued at $1,424,000 after buying an additional 27,670 shares during the period. Mutual of America Capital Management LLC lifted its holdings in shares of Acadia Healthcare by 47.8% in the 2nd quarter. Mutual of America Capital Management LLC now owns 409,179 shares of the company’s stock valued at $20,205,000 after buying an additional 132,356 shares during the period. American Century Companies Inc. lifted its holdings in shares of Acadia Healthcare by 5.3% in the 2nd quarter. American Century Companies Inc. now owns 130,941 shares of the company’s stock valued at $6,466,000 after buying an additional 6,553 shares during the period. Finally, Oak Ridge Investments LLC lifted its holdings in shares of Acadia Healthcare by 2.8% in the 2nd quarter. Oak Ridge Investments LLC now owns 951,981 shares of the company’s stock valued at $47,009,000 after buying an additional 26,043 shares during the period.

WARNING: “Stevens Capital Management LP Purchases New Holdings in Acadia Healthcare Company, Inc. (ACHC)” was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another site, it was copied illegally and republished in violation of US & international copyright & trademark law. The correct version of this piece can be accessed at https://www.watchlistnews.com/stevens-capital-management-lp-purchases-new-holdings-in-acadia-healthcare-company-inc-achc/1699704.html.

In other Acadia Healthcare news, COO Ronald Morgan Fincher sold 80,000 shares of the firm’s stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total transaction of $4,055,200.00. Following the completion of the transaction, the chief operating officer now owns 59,071 shares of the company’s stock, valued at $2,994,308.99. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Joey A. Jacobs sold 500,000 shares of Acadia Healthcare stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $25,345,000.00. Following the completion of the sale, the chief executive officer now directly owns 201,496 shares of the company’s stock, valued at approximately $10,213,832.24. The disclosure for this sale can be found here. Insiders have sold 1,824,040 shares of company stock valued at $92,460,588 in the last three months. 11.10% of the stock is currently owned by company insiders.

Several analysts have recently commented on ACHC shares. William Blair started coverage on Acadia Healthcare in a report on Tuesday, July 18th. They issued an “outperform” rating for the company. BMO Capital Markets initiated coverage on Acadia Healthcare in a report on Monday, October 16th. They set an “outperform” rating and a $52.00 price objective for the company. Zacks Investment Research cut Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Thursday, October 12th. Mizuho set a $60.00 price objective on Acadia Healthcare and gave the stock a “buy” rating in a report on Tuesday, October 24th. Finally, Jefferies Group LLC set a $60.00 price objective on Acadia Healthcare and gave the stock a “buy” rating in a report on Wednesday, October 11th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the company. Acadia Healthcare currently has a consensus rating of “Hold” and an average target price of $45.15.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) opened at $28.23 on Monday. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.30. The firm has a market capitalization of $2,480.11, a price-to-earnings ratio of 12.33, a price-to-earnings-growth ratio of 1.05 and a beta of 0.89. Acadia Healthcare Company, Inc. has a 1 year low of $27.88 and a 1 year high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.07). The company had revenue of $716.70 million for the quarter, compared to analysts’ expectations of $728.86 million. Acadia Healthcare had a return on equity of 8.57% and a net margin of 6.07%. The business’s quarterly revenue was down 2.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.58 EPS. sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 2.23 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.